Open Access
Issue
Med Sci (Paris)
Volume 40, Number 2, Février 2024
Page(s) 121 - 123
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2023205
Published online 27 February 2024
  1. Gajewski TF, Schumacher T. Cancer immunotherapy. Curr Opin Immunol 2013 ; 25 : 259–260. [CrossRef] [PubMed] [Google Scholar]
  2. André T, Shiu K-K, Kim TW, et al. Pembrolizumab in microsatellite-instability- high advanced colorectal cancer. N Engl J Med 2020; 383 : 2 207–18. [CrossRef] [PubMed] [Google Scholar]
  3. Feliu V, Gomez-Roca C, Michelas M, et al. Distant antimetastatic effect of enterotropic colon cancer-derived α4β7 + CD8 + T cells. Sci Immunol 2023; 8 : eadg8841. [CrossRef] [PubMed] [Google Scholar]
  4. Berlin C, Berg EL, Briskin MJ, et al. α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993 ; 74 : 185–195. [CrossRef] [PubMed] [Google Scholar]
  5. Trimaglio G, Tilkin-Mariamé A-F, Feliu V, et al. Colon-specific immune microenvironment regulates cancer progression versus rejection. Oncoimmunology 2020; 9 : 1790125. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.